PURPOSE: Toll-like receptor (TLR) 2 can heterodimerise with TLR6 to detect diacylated lipoproteins. Hypoxia inducible factor-1 α co-ordinates selective induction of TLR2 and TLR6 during persistent hypoxia. We hypothesized that TLR 2/6 co-expression may be upregulated by chronic intermittent hypoxia with re-oxygenation (IHR) in obstructive sleep apnea (OSA). METHODS: TLR2/6 expressions on blood immune cells were measured in 144 patients with sleep-disordered breathing (SDB), including primary snoring (PS, n = 24), moderate to severe OSA (MSO, n = 60), very severe OSA (VSO, n = 36), and very severe OSA on continuous positive airway pressure (CPAP) treatment (VSOC, n = 24). An in vitro IHR experiment was also undertaken. RESULTS: Patients in both the MSO and VSO groups had increased TLR2/6 co-expression on CD16(+) neutrophil than those in the PS group. Patients in the VSOC group had reduced TLR2/6 co-expression on neutrophil than those in either the MSO or VSO group. Blood absolute neutrophil count was positively but weakly correlated with TLR2/6 co-expression on neutrophil. TLR2/6 co-expressions on both CD14(+) monocyte and CD3(+)CD4(+)T helper cell, and TLR2 expressions on both monocyte and T helper cell in SDB patients with low Minimum SaO₂ (≦70%) were all higher than those with high Minimum SaO₂. In vitro IHR for 1-4 days resulted in TLR2/6 co-upregulation on both neutrophil and monocyte. CONCLUSIONS: OSA patients had increased TLR2/6 co-expressions on blood immune cells, which were related to their immune cell counts and could be reversed with CPAP treatment. In vitro IHR could induce TLR2/6 co-upregulation.
PURPOSE: Toll-like receptor (TLR) 2 can heterodimerise with TLR6 to detect diacylated lipoproteins. Hypoxia inducible factor-1 α co-ordinates selective induction of TLR2 and TLR6 during persistent hypoxia. We hypothesized that TLR 2/6 co-expression may be upregulated by chronic intermittent hypoxia with re-oxygenation (IHR) in obstructive sleep apnea (OSA). METHODS:TLR2/6 expressions on blood immune cells were measured in 144 patients with sleep-disordered breathing (SDB), including primary snoring (PS, n = 24), moderate to severe OSA (MSO, n = 60), very severe OSA (VSO, n = 36), and very severe OSA on continuous positive airway pressure (CPAP) treatment (VSOC, n = 24). An in vitro IHR experiment was also undertaken. RESULTS:Patients in both the MSO and VSO groups had increased TLR2/6 co-expression on CD16(+) neutrophil than those in the PS group. Patients in the VSOC group had reduced TLR2/6 co-expression on neutrophil than those in either the MSO or VSO group. Blood absolute neutrophil count was positively but weakly correlated with TLR2/6 co-expression on neutrophil. TLR2/6 co-expressions on both CD14(+) monocyte and CD3(+)CD4(+)T helper cell, and TLR2 expressions on both monocyte and T helper cell in SDB patients with low Minimum SaO₂ (≦70%) were all higher than those with high Minimum SaO₂. In vitro IHR for 1-4 days resulted in TLR2/6 co-upregulation on both neutrophil and monocyte. CONCLUSIONS: OSA patients had increased TLR2/6 co-expressions on blood immune cells, which were related to their immune cell counts and could be reversed with CPAP treatment. In vitro IHR could induce TLR2/6 co-upregulation.
Authors: Xiaoxia Z West; Nikolay L Malinin; Alona A Merkulova; Mira Tischenko; Bethany A Kerr; Ernest C Borden; Eugene A Podrez; Robert G Salomon; Tatiana V Byzova Journal: Nature Date: 2010-10-03 Impact factor: 49.962
Authors: Alex C Chin; Bénédicte Fournier; Eric J Peatman; Titus A Reaves; Winston Y Lee; Charles A Parkos Journal: J Immunol Date: 2009-10-07 Impact factor: 5.422
Authors: Linnea Stridh; Peter L P Smith; Andrew S Naylor; Xiaoyang Wang; Carina Mallard Journal: J Neuroinflammation Date: 2011-05-10 Impact factor: 8.322
Authors: D Polsek; N Gildeh; D Cash; R Winsky-Sommerer; S C R Williams; F Turkheimer; G D Leschziner; M J Morrell; I Rosenzweig Journal: Neurosci Biobehav Rev Date: 2017-12-07 Impact factor: 8.989
Authors: Wioletta Olejarz; Alicja Głuszko; Agata Cyran; Katarzyna Bednarek-Rajewska; Robert Proczka; David F Smith; Stacey L Ishman; Ewa Migacz; Wojciech Kukwa Journal: Sleep Breath Date: 2020-02-20 Impact factor: 2.816
Authors: Dora Polsek; Diana Cash; Mattia Veronese; Katarina Ilic; Tobias C Wood; Milan Milosevic; Svjetlana Kalanj-Bognar; Mary J Morrell; Steve C R Williams; Srecko Gajovic; Guy D Leschziner; Dinko Mitrecic; Ivana Rosenzweig Journal: Sci Rep Date: 2020-07-10 Impact factor: 4.379